Skip to main content
Top

15-03-2024 | Acute Kidney Injury | IM - ORIGINAL

High versus low chloride load in adult hyperglycemic emergencies with acute kidney injury: a multicenter retrospective cohort study

Authors: Kyosuke Takahashi, Norimichi Uenishi, Masamitsu Sanui, Shigehiko Uchino, Naoki Yonezawa, Tetsuhiro Takei, Norihiro Nishioka, Hirotada Kobayashi, Shunichi Otaka, Kotaro Yamamoto, Hideto Yasuda, Shintaro Kosaka, Hidehiko Tokunaga, Naoki Fujiwara, Takashiro Kondo, Tomoki Ishida, Takayuki Komatsu, Koji Endo, Taiki Moriyama, Takayoshi Oyasu, Mineji Hayakawa, Atsumi Hoshino, Tasuku Matsuyama, Yuki Miyamoto, Akihiro Yanagisawa, Tadamasa Wakabayashi, Takeshi Ueda, Tetsuya Komuro, Toshiro Sugimoto, Yusuke Sasabuchi

Published in: Internal and Emergency Medicine

Login to get access

Abstract

Hyperglycemic emergencies frequently lead to acute kidney injury (AKI) and require treatment with large amount of intravenous fluids. However, the effects of chloride loading on this population have not yet been investigated. We conducted a multicenter, retrospective, cohort study in 21 acute-care hospitals in Japan. The study included hospitalized adult patients with diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic syndrome (HHS) who had AKI upon arrival. The patients were classified into high and low chloride groups based on the amount of chloride administered within the first 48 h of their arrival. The primary outcome was recovery from AKI; secondary outcome was major adverse kidney events within 30 days (MAKE30), including mortality and prolonged renal failure. A total of 390 patients with AKI, including 268 (69%) with DKA and 122 (31%) with HHS, were included in the study. Using the criteria of Kidney Disease Improving Global Outcomes, the severity of AKI in the patients was Stage 1 (n = 159, 41%), Stage 2 (n = 121, 31%), and Stage 3 (n = 110, 28%). The analysis showed no significant difference between the two groups in recovery from AKI (adjusted hazard ratio, 0.96; 95% CI 0.72–1.28; P = 0.78) and in MAKE30 (adjusted odds ratio, 0.91; 95% CI 0.45–1.76; P = 0.80). Chloride loading with fluid administration had no significant impact on recovery from AKI in patients with hyperglycemic emergencies.
Trial Registration This study was registered in the UMIN clinical trial registration system (UMIN000025393, registered December 23, 2016).
Appendix
Available only for authorised users
Literature
9.
go back to reference Scott AR, Joint British Diabetes Societies (JBDS) for Inpatient Care, the JBDS hyperosmolar hyperglycaemic guidelines group (2015) Management of hyperosmolar hyperglycaemic state in adults with diabetes. Diabet Med 32:714–724. https://doi.org/10.1111/dme.12757 Scott AR, Joint British Diabetes Societies (JBDS) for Inpatient Care, the JBDS hyperosmolar hyperglycaemic guidelines group (2015) Management of hyperosmolar hyperglycaemic state in adults with diabetes. Diabet Med 32:714–724. https://​doi.​org/​10.​1111/​dme.​12757
18.
go back to reference Ramanan M, Attokaran A, Murray L, Bhadange N, Stewart D, Rajendran G et al (2021) Sodium chloride or Plasmalyte-148 evaluation in severe diabetic ketoacidosis (SCOPE-DKA): a cluster, crossover, randomized, controlled trial. Intensive Care Med 47:1248–1257PubMed Ramanan M, Attokaran A, Murray L, Bhadange N, Stewart D, Rajendran G et al (2021) Sodium chloride or Plasmalyte-148 evaluation in severe diabetic ketoacidosis (SCOPE-DKA): a cluster, crossover, randomized, controlled trial. Intensive Care Med 47:1248–1257PubMed
32.
go back to reference Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI et al (2001) Management of hyperglycemic crises in patients with diabetes. Diabetes Care 24:131–5332CrossRefPubMed Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI et al (2001) Management of hyperglycemic crises in patients with diabetes. Diabetes Care 24:131–5332CrossRefPubMed
35.
go back to reference Dhatariya KK, Joint British Diabetes Societies for Inpatient Care (2022) The management of diabetic ketoacidosis in adults—an updated guideline from the Joint British Diabetes Society for Inpatient Care. Diabet Med 39:e14788. https://doi.org/10.1111/dme.14788 Dhatariya KK, Joint British Diabetes Societies for Inpatient Care (2022) The management of diabetic ketoacidosis in adults—an updated guideline from the Joint British Diabetes Society for Inpatient Care. Diabet Med 39:e14788. https://​doi.​org/​10.​1111/​dme.​14788
Metadata
Title
High versus low chloride load in adult hyperglycemic emergencies with acute kidney injury: a multicenter retrospective cohort study
Authors
Kyosuke Takahashi
Norimichi Uenishi
Masamitsu Sanui
Shigehiko Uchino
Naoki Yonezawa
Tetsuhiro Takei
Norihiro Nishioka
Hirotada Kobayashi
Shunichi Otaka
Kotaro Yamamoto
Hideto Yasuda
Shintaro Kosaka
Hidehiko Tokunaga
Naoki Fujiwara
Takashiro Kondo
Tomoki Ishida
Takayuki Komatsu
Koji Endo
Taiki Moriyama
Takayoshi Oyasu
Mineji Hayakawa
Atsumi Hoshino
Tasuku Matsuyama
Yuki Miyamoto
Akihiro Yanagisawa
Tadamasa Wakabayashi
Takeshi Ueda
Tetsuya Komuro
Toshiro Sugimoto
Yusuke Sasabuchi
Publication date
15-03-2024
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-024-03556-0
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.